Estimated Control Announced Transaction verified Beautybody careCPGHair Carepremium skincareSkin Care

Dr. Barbara Sturm acquired by Puig

Puig agreed to acquire Dr. Barbara Sturm, a premium skincare brand, on Jan 1, 2024.

Transaction summary

Target
Dr. Barbara Sturm
Acquirer
Puig
Seller
-
Announced
2024-01-01
Geography
-
Type
Acquisition
Deal type
Control
Stake acquired
-
First added
2026-06-09
Latest update
2026-10-21

Value and multiples

100% enterprise value

EUR 320M

100% enterprise value | EUR

Basis: FundComb estimate

Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.

Approx. $354M USD using FX date 2023-12-29 at 1.1050 EUR/USD.

EV / revenue

5x

Period not stated

Basis: FundComb estimate

EV / EBITDA

-

EBITDA basis not stated

Basis: FundComb estimate

Basis

  • FundComb’s comps spreadsheet values Dr. Barbara Sturm at EUR 320m, used as the whole-company enterprise value, with revenue of EUR 64m: 5.0x revenue. The revenue period is not stated. These are FundComb estimates, not confirmed by a public source. Puig’s announcement confirms its majority-stake acquisition but does not disclose the price.

Other reviewed estimates

Earlier estimates and their sources.

Puig Brands (PUIG) H2 2024 Summary | Quartr
Revenue EUR 51.6m | EV / revenue 6.2x
Open evidence

Source summary

Puig Acquires Majority Stake in Dr. Barbara Sturm | Puig

Estimated

Puig announced the acquisition of a majority stake in Dr. Barbara Sturm, a premium skincare brand. The founder retained a minority stake and continued in product development and brand ambassador roles.

Open source

Puig Brands (PUIG) H2 2024 Summary | Quartr

Estimated

Summary notes Puig acquired 65% of Dr. Barbara Sturm and that FY2024 net revenue growth included a 1.2% contribution from the acquisition.

Open source

Continue your research

Explore more comps →